The community protocol is 1 mg tesamorelin + 300 mcg ipamorelin subcutaneously, once daily in the evening before bed, 5 days on / 2 days off, for 8 weeks on / 8 weeks off
KLOW (80MG UNIT) $109.99 BPC157 +TB500 + GHK-CU + KPV (10+10+50+10) BLEND BPC157+TB500 +GHK-CU+KPV Research Grade Peptide Overview Overview KLOW is a research-grade peptide combination of BPC157, TB500 (Thymosin 4 acetate), GHK-Cu, and KPV formulated for in vitro investigation of coordinated cellular synthesis, endothelial dynamics, biochemical response signaling, and cytoskeletal remodeling
It also contains vitamin D and hydroxymethylbutyrate (HMB), an organic acid derived from the metabolism of leucine
Water, Dipropylene Glycol, Glycerin, Cyclopentasiloxane, Cyclohexasiloxane, Niacinamide, Dimethicone, Butylene Glycol Dicaprylate/Dicaprate, Cetearyl Alcohol, Glutathione(100ppm), Fucus Vesiculosus Extract, Prunella Vulgaris Extract, Camellia Sinensis Leaf Extract, Artemisia Princeps Leaf Extract, Centella Asiatica Extract, Hamamelis Virginiana (Witch Hazel) Leaf Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hippophae Rhamnoides Fruit Extract, Nelumbo Nucifera Extract, Solanum Melongena (Eggplant) Fruit Extract